Thrombosis and hemostasis biomarkers market to reach $7.37 billion by 2030 at 7.3% CAGR, driven by growing demand for precise and targeted therapies.
Read More
Thrombophilia market to reach $26.5 billion by 2030 at 7.8% CAGR, driven by increasing prevalence of thrombophilic conditions and growing diagnostic awareness.
Read More
Throat sprays market to reach $1.31 billion by 2030 at 5.4% CAGR, driven by increasing incidences of respiratory infections linked to pollution and seasonal illnesses.
Read More
Throat lozenges market to reach $7.29 billion by 2030 at 6.7% CAGR, driven by increasing prevalence of respiratory diseases causing sore throat and irritation.
Read More
Thin film drug manufacturing market to reach $13.35 billion by 2030 at 8.9% CAGR, driven by increase in the global elderly population requiring patient-friendly drug delivery.
Read More
Therapeutic proteins market to reach $332.37 billion by 2030 at 13.5% CAGR, driven by technological advancements in protein engineering and rising prevalence of chronic diseases.
Read More
Therapeutic nutrients and minerals market to reach $113.35 billion by 2030 at 7.6% CAGR, driven by increasing demand for functional foods offering targeted health benefits.
Read More
Therapeutic nuclear drug market to reach $4.27 billion by 2030 at 14.3% CAGR, driven by increasing prevalence of cancer and growing adoption of targeted radiopharmaceutical therapies.
Read More
Therapeutic bcg vaccines market to reach $80.4 billion by 2030 at 6.4% CAGR, driven by rising number of tuberculosis cases worldwide increasing demand for effective immunotherapies.
Read More
Thalassemia drugs market to reach $4.11 billion by 2030 at 10.6% CAGR, driven by increasing healthcare expenditure supporting improved infrastructure and access to specialized treatments.
Read More